发明名称 ANTI-ALPHAVBETA3 HUMANIZED MONOCLONAL ANTIBODIES
摘要 <p>An altered antibody which is specifically reactive with the human alpha vbeta 3 protein receptor and capable of neutralising the receptor, comprising a heavy chain comprising at least one complementarity determining region (CDR) sequence of the 117aa (encoded by the 351 bp sequence given in the specification), and functional fragments of the antibody. Also claimed are: (1) an isolated nucleic acid molecule selected from: (a) a nucleic acid sequence encoding any of the antibodies and fragments as above; (b) a nucleic acid complementary to any of the sequences in (a); and (c) a nucleic acid sequence of 18 or more nucleotides capable of hybridising to (a) or (b) under stringent conditions; (2) a recombinant plasmid comprising the nucleic acid sequence as in (1); (3) a host cell comprising a plasmid as in (2); (4) a murine monoclonal antibody (MAb) and functional fragments, specifically reactive with the human alpha vbeta 3 receptor and capable of neutralising the receptor, having a heavy chain comprising at least one CDR sequence of another 117aa (encoded by another 351 bp sequence given in the specification).</p>
申请公布号 EP0968290(B1) 申请公布日期 2004.12.15
申请号 EP19980909183 申请日期 1998.03.12
申请人 SMITHKLINE BEECHAM CORPORATION 发明人 JONAK, ZDENKA, L.;JOHANSON, KYUNG, O.;TAYLOR, ALEXANDER, H.
分类号 C12N15/09;A61K38/00;A61K39/395;A61K45/00;A61P9/00;A61P9/10;A61P27/02;A61P29/00;A61P35/00;A61P35/04;A61P43/00;C07K16/28;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N5/20;C12N15/13;C12P21/02;C12P21/08;(IPC1-7):C12N15/13;G01N33/577;G01N33/68 主分类号 C12N15/09
代理机构 代理人
主权项
地址